Basel Medical Group Ltd [BMGL] stock prices are down -24.24% to $2.25 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BMGL shares have gain 30.81% over the last week, with a monthly amount drifted -44.99%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Basel Medical Group Ltd [BMGL] has been fluctuating between $0.91 and $9.40 over the past year. Basel Medical Group Ltd [NASDAQ: BMGL] shares were valued at $2.25 at the most recent close of the market.
Analyzing the BMGL fundamentals
The Basel Medical Group Ltd [NASDAQ:BMGL] reported sales of 7.48M for trailing twelve months, representing a surge of 0.72%. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.22%, Pretax Profit Margin comes in at 0.24%, and Net Profit Margin reading is 0.21%. To continue investigating profitability, this company’s Return on Assets is posted at 0.13, Equity is 0.32 and Total Capital is 0.24. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.57.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.91 points at the first support level, and at 1.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.79, and for the 2nd resistance point, it is at 3.32.
Ratios To Look Out For
It’s worth pointing out that Basel Medical Group Ltd [NASDAQ:BMGL]’s Current Ratio is 1.64. In addition, the Quick Ratio stands at 1.63 and the Cash Ratio stands at 0.27. Considering the valuation of this stock, the price to sales ratio is 5.65, the price to book ratio is 7.93 and price to earnings (TTM) ratio is 105.63.
